Why We Increased The Position In Johnson & Johnson
Baron Capital has increased its position in Johnson & Johnson, a prominent healthcare company. The company is concentrating on its Innovative Medicine and MedTech segments, which include oncology and robotic surgery. Johnson & Johnson generates substantial free cash flow, enabling reinvestment and shareholder returns.
- ▪Baron Capital has increased its position in Johnson & Johnson.
- ▪The company focuses on Innovative Medicine and MedTech segments.
- ▪Johnson & Johnson generates over $20 billion in free cash flow annually.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://seekingalpha.com/"},{"@type":"ListItem","position":2,"name":"Healthcare ","item":"https://seekingalpha.com/stock-ideas/healthcare"}]}{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4909331-johnson-and-johnson-stock-why-increased-position"},"author":{"@type":"Person","name":"Baron Capital","url":"https://seekingalpha.com/author/baron-capital"},"publisher":{"@context":"http://schema.org","@type":"Organization","address":{"@type":"PostalAddress","streetAddress":"244 5th Ave","addressLocality":"New…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
